(VIANEWS) – LeMaitre Vascular (LMAT), Fidus Investment Corporation (FDUS), InMode Ltd. (INMD) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. LeMaitre Vascular (LMAT)
22.6% sales growth and 9.31% return on equity
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular patches, which are used for closure of vessels after surgical intervention; closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Earnings Per Share
As for profitability, LeMaitre Vascular has a trailing twelve months EPS of $1.13.
PE Ratio
LeMaitre Vascular has a trailing twelve months price to earnings ratio of 42.42. Meaning, the purchaser of the share is investing $42.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.31%.
2. Fidus Investment Corporation (FDUS)
14.5% sales growth and 8.8% return on equity
Fidus Investment Corporation is a business development company. It specializing in leveraged buyouts, refinancings, change of ownership transactions, recapitalizations, strategic acquisitions, mezzanine, growth capital, business expansion, lower middle market investments, debt investments, subordinated and second lien loans, senior secured and unitranche debt, preferred equity, warrants, subordinated debt, senior subordinated notes, junior secured loans, and unitranche loans. It does not invest in turnarounds or distressed situations. The fund prefers to invest in aerospace and defense, business services, consumer products and services including retail, food, and beverage, healthcare products and services, industrial products and services, information technology services, niche manufacturing, transportation and logistics, and value-added distribution sectors. It seeks to invest in companies based in United States. The fund typically invests between $5 million and $15 million per transaction in companies with annual revenues between $10 million and $150 million and an annual EBITDA between $3 million and $20 million, but it can occasionally invest in larger or smaller companies. It seeks to acquire minority equity stakes and board observation rights in conjunction with its investments.
Earnings Per Share
As for profitability, Fidus Investment Corporation has a trailing twelve months EPS of $1.72.
PE Ratio
Fidus Investment Corporation has a trailing twelve months price to earnings ratio of 10.62. Meaning, the purchaser of the share is investing $10.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.8%.
Yearly Top and Bottom Value
Fidus Investment Corporation’s stock is valued at $18.26 at 06:22 EST, way under its 52-week high of $21.26 and higher than its 52-week low of $17.21.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 21.6% and 17.6%, respectively.
Sales Growth
Fidus Investment Corporation’s sales growth is 24.3% for the ongoing quarter and 14.5% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 18, 2023, the estimated forward annual dividend rate is 2.29 and the estimated forward annual dividend yield is 12.56%.
3. InMode Ltd. (INMD)
14.2% sales growth and 32.66% return on equity
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.
Earnings Per Share
As for profitability, InMode Ltd. has a trailing twelve months EPS of $2.13.
PE Ratio
InMode Ltd. has a trailing twelve months price to earnings ratio of 9.25. Meaning, the purchaser of the share is investing $9.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.66%.
Volume
Today’s last reported volume for InMode Ltd. is 2346780 which is 32.21% above its average volume of 1775020.
Yearly Top and Bottom Value
InMode Ltd. ‘s stock is valued at $19.70 at 06:22 EST, way under its 52-week high of $48.25 and above its 52-week low of $19.27.
Sales Growth
InMode Ltd. ‘s sales growth is 16.6% for the ongoing quarter and 14.2% for the next.
Moving Average
InMode Ltd. ‘s worth is way below its 50-day moving average of $32.99 and way below its 200-day moving average of $35.33.
4. Merchants Bancorp (MBIN)
13.1% sales growth and 16.92% return on equity
Merchants Bancorp operates as the diversified bank holding company in the United States. It operates through Multi-family Mortgage Banking, Mortgage Warehousing, and Banking segments. The Multi-family Mortgage Banking segment engages in the mortgage banking, which originates and services government sponsored mortgages including bridge financing products to refinance, acquire, or reposition multi-family housing projects, and construction lending for multi-family and healthcare facilities; offers customized loan products for need-based skilled nursing facilities, independent living, assisted living, and memory care; and tax credit equity syndicator. Its Mortgage Warehousing segment funds agency eligible residential loans including origination, purchase, and sale in the secondary market, as well as commercial loans to non-depository financial institutions. The Banking segment offers a range of financial products and services to consumers and businesses, which includes retail banking, commercial lending, agricultural lending, retail and correspondent residential mortgage banking, and small business administration lending. Merchants Bancorp was founded in 1990 and is headquartered in Carmel, Indiana.
Earnings Per Share
As for profitability, Merchants Bancorp has a trailing twelve months EPS of $4.71.
PE Ratio
Merchants Bancorp has a trailing twelve months price to earnings ratio of 5.67. Meaning, the purchaser of the share is investing $5.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.92%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.5%, now sitting on 445.32M for the twelve trailing months.
Previous days news about Merchants Bancorp(MBIN)
- According to Zacks on Thursday, 26 October, "Farmers & Merchants Bancorp Inc. (FMAO Quick QuoteFMAO – Free Report) , another stock in the broader Zacks Finance sector, has yet to report results for the quarter ended September 2023.", "Farmers & Merchants Bancorp Inc.’s revenues are expected to be $24.1 million, down 8.4% from the year-ago quarter."
- Merchants bancorp (mbin) beats Q3 earnings and revenue estimates. According to Zacks on Thursday, 26 October, "While Merchants Bancorp has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
- Merchants bancorp (mbin) Q3 earnings: taking a look at key metrics versus estimates. According to Zacks on Thursday, 26 October, "Here is how Merchants Bancorp performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
- Compared to estimates, farmers & merchants bancorp inc. (fmao) Q3 earnings: A look at key metrics. According to Zacks on Thursday, 26 October, "For the quarter ended September 2023, Farmers & Merchants Bancorp Inc. (FMAO Quick QuoteFMAO – Free Report) reported revenue of $23.33 million, down 11.4% over the same period last year. ", "Here is how Farmers & Merchants Bancorp Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
5. Huron Consulting Group (HURN)
5.8% sales growth and 12.95% return on equity
Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. Its Healthcare segment provides advisory services in the areas of financial and operational improvement, care transformation, and revenue cycle managed services; organizational transformation; and digital, technology and analytic solutions to national and regional hospitals, integrated health systems, academic medical centers, community hospitals, and medical groups. The company's Business Advisory segment offers cloud-based technology, analytics, restructuring, and capital advisory solutions to life science, financial, healthcare, education, energy and utilities, and industrials and manufacturing industries, as well as to public sectors. Its Education segment provides research enterprise and student lifecycle; digital, technology and analytic solutions; and organizational transformation services to public and private colleges and universities, academic medical centers, research institutes, and other not-for-profit organizations. Huron Consulting Group Inc. was incorporated in 2002 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, Huron Consulting Group has a trailing twelve months EPS of $3.61.
PE Ratio
Huron Consulting Group has a trailing twelve months price to earnings ratio of 28.78. Meaning, the purchaser of the share is investing $28.78 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.95%.
Volume
Today’s last reported volume for Huron Consulting Group is 28943 which is 75.56% below its average volume of 118445.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 15.8% and a drop 1.8% for the next.
